Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-224
Closed -$18.1K 615
2023
Q1
$18.1K Buy
+224
New +$18K ﹤0.01% 362
2022
Q1
Sell
-107
Closed -$8K 539
2021
Q4
$8K Buy
+107
New +$7.87K ﹤0.01% 509

Other funds holding HOLX

Arlington Partners's HOLX Position: Q2 2023 in Review

Arlington Partners sold out of Hologic (HOLX) in Q2 2023, closing a stake of 224 shares — an estimated $18.1K sold.

Arlington Partners first reported a position in HOLX in Q4 2021 and held it in 2 quarters. The position peaked at $18.1K in Q1 2023. 712 funds tracked by Wall St. Rank hold HOLX as of Q2 2023.

  • Arlington Partners reported no remaining Hologic position as of Q2 2023 after selling out during the quarter.
  • Arlington Partners sold 224 Hologic shares in Q2 2023, an estimated $18.1K.
  • Arlington Partners first reported a position in Hologic in Q4 2021 and held it in 2 quarters.
  • Arlington Partners's Hologic position peaked at $18.1K in Q1 2023.
  • 712 funds tracked by Wall St. Rank held Hologic as of Q2 2023.

Based on Arlington Partners's 13F filing for Q2 2023, filed 26 Jul 2023.